For years PBMs have been assailed by pharma companies and Congress, and the new Trump administration looks likely to keep up the barrage.
CVS Health reported $1.6 billion in profit for the fourth quarter, down from a $2 billion haul a year ago, according to its ...
Walgreens-Boots Alliance struggles with margin compression, competition, and financial risks. Learn why these challenges make ...
When it comes to high drug costs for consumers, pharmacy benefit managers are not the villains, the new CVS chief executive said Wednesday. When it comes to high drug costs for consumers, pharmacy ...
Outrage against PBMs was on full display when 400 pharmacy professionals in Kansas shuttered their businesses and petitioned ...
PBM reform represents a tremendous opportunity. It might be one of the only significant, consequential areas of true ...
The FTC has asked the six largest PBMs operating in the US market – CVS Caremark, Express Scripts, OptumRx, Humana, Prime Therapeutics and MedImpact Healthcare Systems – to hand over detailed ...
The Federal Trade Commission (FTC) has sued the top three pharmacy benefit managers (PBMs) in the US for operating a "perverse drug rebate system" that it claims artificially inflated the prices ...
Pharmacy retailer CVS Health Inc. (NYSE:CVS) is scheduled to report its fourth quarter 2024 earnings on Wednesday,2. Wall ...
Medicare managed care plans will receive an increase of just over 6.5% on average in per capita payments when the rates for 2005 are announced in May, according to a preliminary estimate from the ...
The Federal Trade Commission filed a lawsuit against PBMs last September, alleging their “unfair” rebating practices “artificially inflated” the price of insulin. In 2022, the FTC launched ...
As prescription drug prices continue to spiral and federal efforts to control them stall, state lawmakers are focusing on ...